Extended Data Fig. 5: Subsequent anticancer treatment.
CTLA-4=cytotoxic T-lymphocyte-associated protein 4; PD-1=programmed cell death protein 1; PD-L1 = programmed death-ligand 1; T-VEC = talimogene laherparepvec.
Extended Data Fig. 5: Subsequent anticancer treatment. | Nature Medicine
